Push Platform
Overview Image
Our Mission
Maximize the knowledge that is gained from interacting with and treating every single patient affected by an ultra-rare sarcoma and to support developing new treatments to improve outcomes and quality of life.
Overview Image
The Need For Push
Why Collaboration Matters More Than Ever
Ultra-rare sarcomas affect fewer than one person per million each year, yet together they represent nearly one-fifth of all sarcoma cases. Their rarity makes it difficult to gather meaningful data, develop treatments, and give patients access to effective therapies. By bringing together clinicians, researchers, advocates, and patients from around the world, PUSH is building the shared platform needed to accelerate discovery and improve outcomes for everyone affected by these diseases.
Retrospective Data Patient Reported Data Registries Translational Data Prospective Observational Data Prospective Clinical Trials (PUSH-IT)
Founding Partners
The PUSH Consortium was established in 2022 following discussion at a meeting of the EORTC Soft Tissue and Bone Sarcoma Group in Munich. The first face to face meeting took place in Dublin, at the annual CTOS meeting, in November 2023. Sarcoma Foundation of America (SFA) is the administrator of the PUSH Platform.
The founding members of the collaboration came from:
Frequently Asked Questions
What is the PUSH Consortium?
The Pushing Ultra-Rare Sarcomas Beyond Hope (PUSH) global consoritum is a collaborative effort dedicated to advancing research and improving outcomes for ultra rare sarcoma histologies through data sharing, patient and advocacy, and specialized working groups.
How can researchers or institutions get involved?
Institutions can get involved by joining our specialized working groups or contributing to research initiatives. Please contact us for more information on how to join a working group or get involved.
Is the data on the PUSH Platform secure?
Yes, the data on the push platform is secure. We prioritize the confidentiality and integrity of all shared data through robust data governance policies and state-of-the-art security.
Shape the future of treatment for ultra-rare sarcomas.
Join our mailing list
Stay connected with PUSH
Be informed about new working groups, research milestones, and opportunities to get involved